Palantir Stock Is Down 35% From Its All-Time High. Should You Buy the Dip?

Palantir's Q1 revenue grew 85% year over year to $1.63 billion, with a 53% net income margin, underscoring strong business momentum tied to its AI product lineup. Despite the operating strength, the stock has fallen about 35% from its October peak and still trades at 152x earnings and 92x forward earnings, keeping valuation concerns front and center. The article is constructive on fundamentals but cautious on the stock's near-term upside given its premium multiple.

Analysis

PLTR is transitioning from a “beat-and-raise” story to a duration risk story: once margins are already extraordinary, incremental upside must come almost entirely from top-line compounding, which makes the multiple far more fragile to any slowdown in government procurement or AIP monetization. That means the stock can stay disconnected from fundamentals longer than skeptics expect, but the asymmetry worsens when expectations are this elevated because even strong quarter-over-quarter execution may not expand the denominator fast enough to de-risk the valuation.

The second-order winner is not necessarily another AI software name, but the picks-and-shovels layer around inference and deployment. If PLTR remains expensive but structurally important, enterprise buyers and public-sector customers may still fund adjacent infrastructure, data plumbing, and model-operations spend while negotiating harder on platform pricing, which caps PLTR’s pricing power but supports NVDA and select enterprise IT beneficiaries. INTC is less directly levered; any spillover is more about generic AI capex narratives than actual share gains, so it likely trades as a sympathy name rather than a true beneficiary.

The contrarian point is that the market may be correctly discounting a future plateau in multiple expansion, not disputing the business quality. When a stock is priced for near-flawless execution, the catalyst to rerate higher is not another strong quarter — it is a major step-up in forward earnings power that changes the terminal growth math. Absent that, the stock can keep consolidating for months even if fundamentals remain excellent, because the path of least resistance is time correction rather than price correction.

Near term, the key risk is not collapse but stagnation: if revenue growth decelerates even modestly over the next 1-2 quarters, the valuation can compress without a headline miss. Over a 6-12 month horizon, the setup favors volatility selling or relative-value expression rather than outright directional longs, unless one has high conviction in a sustained acceleration beyond current consensus.

Key Decisions for Investors

• Maintain a tactical underweight in PLTR for the next 1-3 months; avoid chasing strength until valuation resets or consensus forward EPS revisions materially inflect upward. Risk/reward remains poor versus other AI exposures because the stock needs exceptional compounding just to hold the current multiple.
• For investors needing AI exposure, rotate part of PLTR beta into NVDA on any 5-8% pullback; NVDA has a cleaner capex capture mechanism and less dependence on sustaining an extreme terminal multiple. Use PLTR/NVDA as a relative-value pair if PLTR re-rallies into resistance.
• Consider a PLTR covered-call overlay or call spread into the next earnings window to monetize implied volatility while limiting upside surrender. This fits a view that the stock can remain range-bound for 1-2 quarters even if fundamentals stay strong.
• Pair trade idea: long NVDA / short PLTR sized 1:1 on beta-adjusted notional for a 3-6 month horizon. Thesis: AI spend continues, but monetization shifts toward the infrastructure layer faster than toward high-multiple application platforms.
• Do not use INTC as a direct AI beneficiary proxy here; if owning it, treat it as a separate turnaround/sentiment trade with low linkage to PLTR’s outcome. Any long INTC position should be based on idiosyncratic execution, not spillover from AI enthusiasm.